The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma

HPB (Oxford). 2018 Jan;20(1):83-92. doi: 10.1016/j.hpb.2017.08.025. Epub 2017 Sep 25.

Abstract

Background: Although several classifications of perihilar cholangiocarcinoma (PHC) include vascular involvement, its prognostic value has not been investigated. Our aim was to assess the prognostic value of unilateral and main/bilateral involvement of the portal vein (PV) and hepatic artery (HA) on imaging in patients with PHC.

Methods: All patients with PHC between 2002 and 2014 were included regardless of stage or management. Vascular involvement was defined as apparent tumor contact of at least 180° to the PV or HA on imaging. Kaplan-Meier method with log-rank test was used to compare overall survival (OS) between groups. Cox regression was used for multivariable analysis.

Results: In total, 674 patients were included with a median OS of 12.2 (95% CI 10.6-13.7) months. Patients with unilateral PV involvement had a median OS of 13.3 (11.0-15.7) months, compared with 14.7 (11.7-17.6) in patients without PV involvement (p = 0.12). Patients with main/bilateral PV involvement had an inferior median OS of 8.0 (5.4-10.7, p < 0.001) months. Median OS for patients with unilateral HA involvement was 10.6 (9.3-12.0) months compared with 16.9 (13.2-20.5) in patients without HA involvement (p < 0.001). Patients with main/bilateral HA involvement had an inferior median OS of 6.9 (3.3-10.5, p < 0.001). Independent poor prognostic factors included unilateral and main/bilateral HA involvement, but not PV involvement.

Conclusion: Both unilateral and main HA involvement are independent poor prognostic factors for OS in patients presenting with PHC, whereas PV involvement is not.

MeSH terms

  • Aged
  • Bile Duct Neoplasms / mortality*
  • Bile Duct Neoplasms / pathology*
  • Bile Duct Neoplasms / therapy
  • Female
  • Hepatic Artery / pathology*
  • Humans
  • Kaplan-Meier Estimate
  • Klatskin Tumor / mortality*
  • Klatskin Tumor / pathology*
  • Klatskin Tumor / therapy
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Portal Vein / pathology*
  • Predictive Value of Tests
  • Prognosis
  • Retrospective Studies
  • Survival Rate